Komori
OncoTherapy Science (4564) · TargetRestated

Deliver highly effective cancer treatments with fewer side effects as soon as possible

First written in FY2016. 19 of 20 entries say "Restated". Latest entry: FY2026-H1.

20entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2026-H12016: 320162017: 320172018: 220182019: 220192020: 320202021: 220212022: 220222023: 120232024: 020242025: 22025
Same theme, other companies
Mission to contribute to cancer patients and healthcareA theme 5 companies write about · 0 as a headwind · 5 as a tailwind

4 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1RestatedAnnual report

    「With the corporate mission of "delivering highly effective cancer drugs and treatments with fewer side effects to patients suffering from cancer as soon as possible, and winning the fight against cancer"」

    The Group continues to pursue the goal of delivering cancer drugs and treatments to patients as soon as possible as part of its corporate mission.
  2. FY2025RestatedAnnual report

    「Our Group's corporate mission is "to deliver highly effective cancer drugs and treatments with fewer side effects to patients suffering from cancer as soon as possible, and to win the fight against cancer"」

    The Group continues to state its goal of delivering cancer drugs and treatments to patients as soon as possible as part of its corporate mission.
  3. FY2023-Q3RestatedAnnual report

    「With the corporate mission of "delivering highly effective cancer drugs and treatments with fewer side effects to patients suffering from cancer as soon as possible, and winning the fight against cancer"」

    The Group continues to state its goal of quickly providing patients with highly effective cancer drugs and treatments with fewer side effects as part of its corporate mission.
  4. FY2023-Q1RestatedAnnual report

    「With the corporate mission of "delivering highly effective cancer drugs and treatments with fewer side effects to patients suffering from cancer as soon as possible, and winning the fight against cancer"」

    The Group continues to state its goal of delivering cancer drugs and treatments to patients as soon as possible as part of its corporate mission.
  5. FY2022-Q3RestatedAnnual report

    「With the corporate mission of "delivering highly effective cancer drugs and treatments with fewer side effects to patients suffering from cancer as soon as possible, and winning the fight against cancer"」

    The Group continues to state its goal of quickly providing patients with highly effective cancer drugs and treatments with fewer side effects as part of its corporate mission.
  6. FY2022-Q1RestatedAnnual report

    「With the corporate mission of "delivering highly effective cancer drugs and treatments with fewer side effects to patients suffering from cancer as soon as possible, and winning the fight against cancer"」

    The Group continues to pursue the goal of quickly delivering highly effective treatments with fewer side effects to patients as its corporate mission.
  7. FY2021-Q3RestatedAnnual report

    「With the corporate mission of "delivering highly effective cancer drugs and treatments with fewer side effects to patients suffering from cancer as soon as possible, and winning the fight against cancer"」

    The corporate mission of delivering cancer drugs and treatments to patients as soon as possible continues to be stated.
  8. FY2021-Q2RestatedAnnual report

    「With the corporate mission of "delivering highly effective cancer drugs and treatments with fewer side effects to patients suffering from cancer as soon as possible, and winning the fight against cancer"」

    The Group continues to pursue the goal of quickly delivering highly effective treatments with fewer side effects to patients as its corporate mission.
  9. FY2021-Q1RestatedAnnual report

    「With the corporate mission of "delivering highly effective cancer drugs and treatments with fewer side effects to patients suffering from cancer as soon as possible, and winning the fight against cancer"」

    The Group continues to pursue the goal of quickly delivering highly effective treatments with fewer side effects to patients as its corporate mission.
  10. FY2020-Q3RestatedAnnual report

    「With the corporate mission of "delivering highly effective cancer drugs and treatments with fewer side effects to patients suffering from cancer as soon as possible, and winning the fight against cancer"」

    The corporate mission of delivering cancer drugs and treatments to patients as soon as possible continues to be stated.
  11. FY2020-Q2RestatedAnnual report

    「With the corporate mission of "delivering highly effective cancer drugs and treatments with fewer side effects to patients suffering from cancer as soon as possible, and winning the fight against cancer"」

    The Group continues to state its goal of delivering cancer drugs and treatments to patients as soon as possible as part of its corporate mission.
  12. FY2020-Q1RestatedAnnual report

    「With the corporate mission of "delivering highly effective cancer drugs and treatments with fewer side effects to patients suffering from cancer as soon as possible, and winning the fight against cancer"」

    The Group continues to state its goal of delivering cancer drugs and treatments to patients as soon as possible as part of its corporate mission.
  13. FY2018RestatedAnnual report

    「Our Group's corporate mission is "to deliver highly effective cancer drugs and treatments with fewer side effects to patients suffering from cancer as soon as possible, and to win the fight against cancer"」

    The Group continues to pursue the goal of quickly delivering highly effective treatments with fewer side effects to patients as its corporate mission.
  14. FY2018-Q3RestatedAnnual report

    「In particular, our Group has set as its corporate mission "to deliver highly effective cancer drugs and treatments with fewer side effects to patients suffering from cancer as soon as possible, and to win the fight against cancer"」

    The Group continues to state its goal of delivering cancer drugs and treatments to patients as soon as possible as part of its corporate mission.
  15. FY2018-Q2RestatedAnnual report

    「In particular, our Group has set as its corporate mission "to deliver highly effective cancer drugs and treatments with fewer side effects to patients suffering from cancer as soon as possible, and to win the fight against cancer"」

    The Group continues to state its goal of delivering cancer drugs and treatments to patients as soon as possible as part of its corporate mission.
  16. FY2017RestatedAnnual report

    「As its corporate mission, "to deliver highly effective cancer drugs and treatments with fewer side effects to patients suffering from cancer as soon as possible, and to win the fight against cancer"」

    The corporate mission continues to emphasize providing patients with drugs and treatments as quickly as possible.
  17. FY2017-Q3RestatedAnnual report

    「In particular, our Group has set as its corporate mission "to deliver highly effective cancer drugs and treatments with fewer side effects to patients suffering from cancer as soon as possible, and to win the fight against cancer"」

    The Group continues to state its goal of delivering cancer drugs and treatments to patients as soon as possible as part of its corporate mission.
  18. FY2017-Q2RestatedAnnual report

    「To deliver highly effective cancer drugs and treatments with fewer side effects to patients suffering from cancer as soon as possible, and to win the fight against cancer」

    Continues to be stated as part of the corporate mission.
  19. FY2017-Q1RestatedAnnual report

    「To deliver highly effective cancer drugs and treatments with fewer side effects to patients suffering from cancer as soon as possible, and to win the fight against cancer」

    Continues to be stated as part of the corporate mission.
  20. FY2016First statedAnnual report

    「To deliver highly effective cancer drugs and treatments with fewer side effects to patients suffering from cancer as soon as possible, and to win the fight against cancer」

    A core goal stated as part of the corporate mission.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for OncoTherapy Science yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Deliver highly effective cancer treatments with fewer side effects as soon as possible | OncoTherapy Science,Inc. (4564) | Komori